Bladder Cancer Coverage from Every Angle
Advertisement
Advertisement

Recent News

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: The Debate Continues
Successful Treatment of Rare Case of Urothelial Carcinoma of the Fossa Navicularis
Independent Risk Factors of Bladder Cancer: Perspective From an Iranian Province
Predicting Pathologic Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Can a Centralized, Multidisciplinary Program Improve Outcomes in Muscle-Invasive Bladder Cancer?
Can Sugary Drinks Increase Bladder Cancer Risk?
Risk of Bladder Cancer After Ranitidine Exposure: Danish Population-Based Study
Prevalence of Depression and Risk Factors in Elderly Patients With Bladder Cancer
SITC 2021: Preclinical Study of Microbial Immunotherapy in Bladder Cancer
Vaccine Plus Pembrolizumab Under Study in Non–Muscle-Invasive Bladder Cancer
Patients With Bladder Cancer and a Smoking History: Can Urinary pH Predict Recurrence?
Can Smoking-Related DNA Methylation Markers Help to Predict Urothelial Cancer Risk?
How Many Cycles of Cisplatin-Based Chemotherapy Before Cystectomy Is Enough?
Non–Muscle-Invasive Disease: BCG With or Without Novel Vaccine Tested in Phase II Trial
Radical Cystectomy: Comparing Outcomes by Stage and Type of Bladder Cancer
Subsequent Chemotherapy for Metastatic Urothelial Carcinoma: Is Platinum-Based Therapy of Benefit?
3-Year Outcomes With Perioperative Chemotherapy Regimen for Muscle-Invasive Bladder Cancer
Nectin-4 Expression and Prognosis in Upper Tract Urothelial Cancer
Do Antibiotics Impact the Efficacy of Pembrolizumab in Metastatic Urothelial Carcinoma?
Preoperative Chemotherapy for Muscle-Invasive Bladder Cancer: Is Age Related to Response?
AUA 2021: Antibody Levels as Predictors of Response to Immunotherapy in Bladder Cancer
AUA 2021: Trial Update on Novel Gene-Mediated Therapy for High-Grade Bladder Cancer
ESMO 2021: Erdafitinib Plus Cetrelimab in Advanced Urothelial Carcinoma With FGFR Alterations
AUA 2021: Interim Analysis of Novel Immunotherapy for BCG-Unresponsive Bladder Cancer
ESMO 2021: Bladder Preservation in Older Patients With Muscle-Invasive Bladder Cancer
AUA 2021: Long-Term Analysis of UGN-101 in Upper Tract Urothelial Carcinoma
AUA 2021: Initial Study Findings With Large Surface Area Microparticle Docetaxel in Bladder Cancer
Is Aspirin Intake Associated With Risk of Bladder Cancer or Its Prognosis?
Muscle-Invasive Bladder Cancer: Comparing Trimodal Therapy and Radical Cystectomy
Pembrolizumab Receives Full FDA Approval for Certain Patients With Advanced Urothelial Carcinoma
Novel Approach to Detecting PD-L1 in the Urine of Patients With Bladder Cancer
FDA Approves Nivolumab as First Adjuvant Treatment for High-Risk Urothelial Carcinoma
Can Dietary Tomato Intake Influence the Risk of Bladder Cancer?
Urothelial Carcinoma: Prognostic Factors Associated With Immune Checkpoint Inhibitors
Atezolizumab in Resistant Advanced Urothelial Cancer: Prognostic Significance of Pretreatment Factors
Adding Atezolizumab to Chemotherapy for Muscle-Invasive Bladder Cancer
Update From EV-103: Enfortumab Vedotin-ejfv Plus Pembrolizumab for Advanced Urothelial Carcinoma


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.